GENN — Genesis Healthcare Share Price
Last trade - 00:00- $0.18m
- $985.18m
- $3.91bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 0 | ||
| Price to Sales | 0 | ||
| EV to EBITDA | 7.94 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.49% | ||
| Return on Equity | n/a | ||
| Operating Margin | 0.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 5,732.43 | 5,373.74 | 4,976.65 | 4,565.83 | 3,906.22 | 3,461.78 | n/a | -7.01% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Genesis Healthcare, Inc. is a holding company. The Company provides services to skilled nursing facilities and assisted/senior living communities. It also specializes in contract rehabilitation therapy, respiratory therapy, physician services, staffing services, and accountable care. It provides approximately 250 skilled nursing centers and senior living communities in 22 states nationwide. Its subsidiaries also supply rehabilitation therapy to approximately 1,400 locations in 43 states and the District of Columbia. It offers a range of services, which include rehabilitation therapy, memory support, long-term care, and assisted/senior living. Its rehabilitation therapy includes transitional care, short stay care, ventilator rehabilitation, dialysis, cardiac management, and pulmonary management. Its long-term care service provides 24-hour skilled nursing services for elderly residents and people with a chronic condition or a prolonged illness. It also offers hospice care services.
Directors
- David Harrington CHM (76)
- Harry Wilson CEO
- Thomas DiVittorio CFO (53)
- Paul Bach COO (62)
- Richard Feifer EVP (54)
- JoAnne Reifsnyder EVP (62)
- Michael Sherman SVP (52)
- Robert Fish DRC (70)
- Robert Hartman DRC (64)
- John Randazzo DRC (66)
- Arnold Whitman DRC (69)
- Last Annual
- December 31st, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- October 21st, 2005
- Public Since
- May 15th, 2007
- No. of Shareholders
- 60
- No. of Employees
- 44,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 167,351,103
- Address
- 101 EAST STATE STREET, KENNETT SQUARE, 19348
- Web
- https://www.genesishcc.com/
- Phone
- +1 6104446350
- Auditors
- KPMG LLP
Upcoming Events for GENN
Similar to GENN
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
ACI Global
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
As of Today at 19:09 UTC, shares in Genesis Healthcare are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Genesis Healthcare last closed at $0.00 and the price had moved by -83.33% over the past 365 days. In terms of relative price strength the Genesis Healthcare share price has underperformed the S&P500 Index by -85.6% over the past year.
The overall consensus recommendation for Genesis Healthcare is Sell. You can view the full broker recommendation list by unlocking its StockReport.
Genesis Healthcare does not currently pay a dividend.
Genesis Healthcare does not currently pay a dividend.
Genesis Healthcare does not currently pay a dividend.
To buy shares in Genesis Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Genesis Healthcare had a market capitalisation of $0.18m.
Here are the trading details for Genesis Healthcare:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: GENN
Based on an overall assessment of its quality, value and momentum Genesis Healthcare is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genesis Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -29.4%.
As of the last closing price of $0.00, shares in Genesis Healthcare were trading -41.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Genesis Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Genesis Healthcare's management team is headed by:
- David Harrington - CHM
- Harry Wilson - CEO
- Thomas DiVittorio - CFO
- Paul Bach - COO
- Richard Feifer - EVP
- JoAnne Reifsnyder - EVP
- Michael Sherman - SVP
- Robert Fish - DRC
- Robert Hartman - DRC
- John Randazzo - DRC
- Arnold Whitman - DRC